Assembly Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $7,357 | $6,845 | $8,533 | $5,785 |
Gross Profit | 7,357 | 6,845 | 8,501 | 5,753 |
EBITDA | -11,500 | -10,923 | -12,171 | -10,697 |
EBIT | -11,532 | -10,956 | -12,203 | -10,729 |
Net Income | -10,335 | -9,613 | -11,152 | -9,077 |
Net Change In Cash | 7,357 | 6,845 | 8,533 | 5,785 |
Free Cash Flow | -407 | -15,244 | -17,116 | -18,378 |
Cash | 38,344 | 28,452 | 19,208 | 18,749 |
Basic Shares | 6,004 | 6,351 | 5,642 | 5,483 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $28,520 | $7,163 | $0 | $6,254 |
Gross Profit | 28,520 | -41,737 | -498 | 5,788 |
EBITDA | -45,420 | -64,196 | -93,616 | -91,932 |
EBIT | -64,646 | -94,114 | -92,398 | |
Net Income | -40,177 | -61,228 | -92,070 | -129,855 |
Net Change In Cash | 28,520 | 7,163 | 0 | 6,254 |
Cost of Revenue | 6,791 | |||
Free Cash Flow | -51,145 | 22,488 | -84,565 | -96,492 |
Cash | 38,344 | 19,841 | 52,418 | 45,627 |
Basic Shares | 6,004 | 4,577 | 4,034 | 46,846 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.57 |
2024-09-30 | -$1.51 |
2024-06-30 | -$2.05 |
2024-03-31 | -$1.66 |
